The Effect of Caphosol® on the Development of Esophagitis in (N)SCLC Patients Treated With Concurrent Chemo/Radiotherapy (CARACTER)
The Effect of Caphosol® on the Development of Esophagitis in (N)SCLC Patients Treated With Concurrent Chemo/Radiotherapy A Prospective Study of Caphosol + Standard of Care Versus Standard of Care
Sponsor: Amphia Hospital
Terminated
bad taste of Caphosol - early stop of intake by patients
Other terminated trials from Amphia Hospital
Other Non Small Cell Lung Cancer trials with similar outcome
This NA trial investigates Non Small Cell Lung Cancer and Small Cell Lung Cancer and is currently terminated or withdrawn. Amphia Hospital leads this study, which shows 6 recorded versions since 2014 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
May 2020 — Jan 2021 [monthly]
Terminated NA
Status: Unknown Status → Terminated
-
Jun 2018 — May 2020 [monthly]
Unknown Status NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status NA
First recorded
Feb 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Amphia Hospital
- Erasmus Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .